PROTACs Recruit the Ubiquitin-Proteasome System to Degrade Breast Cancer Proteins
Breast cancer remains the most frequently diagnosed malignancy and a leading cause of cancer death among women worldwide, with more ...
Breast cancer remains the most frequently diagnosed malignancy and a leading cause of cancer death among women worldwide, with more ...
A new computational study suggests that next-generation CRBN E3 ligase modulators, particularly CC-885, may hold the key to overcoming mutation-driven ...
Chemists have developed ruthenium-based photocaged PROTACs, called RuPHOTACs, that can be switched on with low-energy red light to selectively degrade ...
A new review in Molecular Cancer provides a rigorous framework for how liquid–liquid phase separation drives cancer biology and evaluates ...
A new comprehensive review in Discover Chemistry details how PROTACs have evolved from a mechanistic concept into clinically advanced degraders ...
A new review in Molecular Diversity charts the rapid rise of dual PROTACs, single molecules engineered to destroy two disease-driving ...
BET proteins, particularly BRD4, have emerged as pivotal drivers of oncogenic transcription in various solid tumors, presenting a promising but ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine